Your browser doesn't support javascript.
loading
Prevalence of resistance-associated substitutions and retreatment of patients failing a glecaprevir/pibrentasvir regimen.
de Salazar, Adolfo; Dietz, Julia; di Maio, Velia Chiara; Vermehren, Johannes; Paolucci, Stefania; Müllhaupt, Beat; Coppola, Nicola; Cabezas, Joaquín; Stauber, Rudolf E; Puoti, Massimo; Arenas Ruiz Tapiador, Juan Ignacio; Graf, Christiana; Aragri, Marianna; Jimenez, Miguel; Callegaro, Annapaola; Pascasio Acevedo, Juan Manuel; Macias Rodriguez, Manuel Alberto; Rosales Zabal, Jose Miguel; Micheli, Valeria; Garcia Del Toro, Miguel; Téllez, Francisco; García, Federico; Sarrazin, Christoph; Ceccherini-Silberstein, Francesca.
Afiliação
  • de Salazar A; Clinical Microbiology Unit, University Hospital San Cecilio, Instituto de Investigacion Ibs.Granada. Granada, Spain.
  • Dietz J; Department of Internal Medicine 1, University Hospital Frankfurt, Frankfurt, Germany; German Center for Infection Research (DZIF), External Partner Site, Frankfurt, Germany.
  • di Maio VC; Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy.
  • Vermehren J; Department of Internal Medicine 1, University Hospital Frankfurt, Frankfurt, Germany; German Center for Infection Research (DZIF), External Partner Site, Frankfurt, Germany.
  • Paolucci S; Molecular Virology Unit, Microbiology and Virology Department, IRCCS Policlinic Foundation San Matteo, Pavia, Italy.
  • Müllhaupt B; Swiss Hepato-Pancreato-Biliary Center and Department of Gastroenterology and Hepatology, University Hospital Zürich, Zürich, Switzerland.
  • Coppola N; Department of Mental Health and Public Medicine, Infectious Diseases Unit, University of Campania "L. Vanvitelli", Naples, Italy.
  • Cabezas J; Department of Hepatology, Marqués de Valdecilla University Hospital, Santander, Spain.
  • Stauber RE; Department of Gastroenterology and Hepatology, Medical University of Graz, Graz, Austria.
  • Puoti M; Infectious Diseases, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
  • Arenas Ruiz Tapiador JI; Infectious Diseases Unit, University Hospital Donostia, San Sebastián, Spain.
  • Graf C; Department of Internal Medicine 1, University Hospital Frankfurt, Frankfurt, Germany; German Center for Infection Research (DZIF), External Partner Site, Frankfurt, Germany.
  • Aragri M; Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy.
  • Jimenez M; Hepatology Unit, Hospital Regional de Málaga, Málaga, Spain.
  • Callegaro A; Microbiology and Virology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.
  • Pascasio Acevedo JM; Hepatology Unit, University Hospital Virgen del Rocío, Seville, Spain.
  • Macias Rodriguez MA; Department of Digestive Diseases, Hospital Universitario Puerta del Mar, Cádiz, Spain.
  • Rosales Zabal JM; Gastrointestinal Unit, Hospital Costa del Sol, Marbella, Málaga, Spain.
  • Micheli V; Clinical Microbiology, Virology and Bioemergencies, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.
  • Garcia Del Toro M; Infectious Diseases Unit, Hospital General de Valencia, Valencia, Spain.
  • Téllez F; Infectious Diseases Unit, Hospital Puerto Real, Puerto Real, Cádiz, Spain.
  • García F; Clinical Microbiology Unit, University Hospital San Cecilio, Instituto de Investigacion Ibs.Granada. Granada, Spain.
  • Sarrazin C; Department of Internal Medicine 1, University Hospital Frankfurt, Frankfurt, Germany; German Center for Infection Research (DZIF), External Partner Site, Frankfurt, Germany.
  • Ceccherini-Silberstein F; Medizinische Klinik 2, St. Josefs Hospital, Wiesbaden, Germany.
J Antimicrob Chemother ; 75(11): 3349-3358, 2020 11 01.
Article em En | MEDLINE | ID: mdl-32772078
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepacivirus / Farmacorresistência Viral Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: J Antimicrob Chemother Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepacivirus / Farmacorresistência Viral Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: J Antimicrob Chemother Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha